E. Groeneveld

561 total citations
19 papers, 480 citations indexed

About

E. Groeneveld is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Groeneveld has authored 19 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 8 papers in Hematology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Groeneveld's work include Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Blood properties and coagulation (5 papers). E. Groeneveld is often cited by papers focused on Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Blood properties and coagulation (5 papers). E. Groeneveld collaborates with scholars based in Netherlands and United States. E. Groeneveld's co-authors include D.C. Rijken, G. Wijngaards, C. Kluft, W. Nieuwenhuizen, J. P. A. van den Bergh, C.M. ten Bruggenkate, D.B. Tuinzing, P. Holzmann, Elisabeth H. Burger and Cornelis Kluft and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Analytical Biochemistry.

In The Last Decade

E. Groeneveld

19 papers receiving 406 citations

Peers

E. Groeneveld

HEMAT

PRM

Sirpa Osman Finland

Pirjo Åström Finland

Shu Abe Japan

J Kishi Japan

Jennifer Freytag United States

Carmel M.T. Horgan United Kingdom

Cynthia E. Wilkins-Port United States

Myung Won Seo South Korea

Shinichi Kurahara Japan

Mariella F. Carlevaro Italy

Sirpa Osman Finland

E. Groeneveld

204 ×0.9

100 ×0.4

HEMAT

117 ×1.1

65 ×0.6

PRM

10 ×0.1

Citations per year, relative to E. Groeneveld E. Groeneveld (= 1×) peers Sirpa Osman

Countries citing papers authored by E. Groeneveld

Since Specialization

Citations

This map shows the geographic impact of E. Groeneveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Groeneveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Groeneveld more than expected).

Fields of papers citing papers by E. Groeneveld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Groeneveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Groeneveld. The network helps show where E. Groeneveld may publish in the future.

Co-authorship network of co-authors of E. Groeneveld

This figure shows the co-authorship network connecting the top 25 collaborators of E. Groeneveld. A scholar is included among the top collaborators of E. Groeneveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Groeneveld. E. Groeneveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Groeneveld, E., et al.. (2002). Characterization of the Binding of Urokinase-Type Plasminogen Activator to the Asialoglycoprotein Receptor. Thrombosis and Haemostasis. 88(7). 83–88. 3 indexed citations

Groeneveld, E., J. P. A. van den Bergh, P. Holzmann, et al.. (1999). Mineralization processes in demineralized bone matrix grafts in human maxillary sinus floor elevations. Journal of Biomedical Materials Research. 48(4). 393–402. 93 indexed citations

Groeneveld, E., et al.. (1999). Mineralization processes in demineralized bone matrix grafts in human maxillary sinus floor elevations. Journal of Biomedical Materials Research. 48(4). 393–402. 8 indexed citations

Rijken, D.C., et al.. (1995). Native and Non-glycosylated Recombinant Single-chain Urokinase-type Plasminogen Activator Are Recognized by Different Receptor Systems on Rat Parenchymal Liver Cells. Thrombosis and Haemostasis. 74(2). 722–729. 5 indexed citations

Rijken, D.C., E. Groeneveld, & Marrie Barrett-Bergshoeff. (1994). In Vitro Stability of a Tissue-Type Plasminogen Activator Mutant, BM 06.022, in Human Plasma. Thrombosis and Haemostasis. 72(6). 906–911. 10 indexed citations

Parkinson, John F., et al.. (1993). Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin. Biochemical Journal. 290(3). 655–659. 20 indexed citations

Groeneveld, E., et al.. (1993). Comparison of the In Vitro Fibrinolytic Activities of Low and High Molecular Weight Single-Chain Urokinase-Type Plasminogen Activator. Thrombosis and Haemostasis. 70(3). 481–485. 10 indexed citations

Groeneveld, E., et al.. (1991). Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.. Journal of Clinical Investigation. 88(5). 1680–1684. 44 indexed citations

Rijken, D.C. & E. Groeneveld. (1991). Substrate specificity of tissue-type and urokinase-type plasminogen activators. Biochemical and Biophysical Research Communications. 174(2). 432–438. 22 indexed citations

10.

Rijken, D C, E. Groeneveld, Cornelis Kluft, & H K Nieuwenhuis. (1988). Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.. PubMed. 255(2). 609–15. 19 indexed citations

11.

Rijken, D.C. & E. Groeneveld. (1988). 281 Substrate specificity of tissue-type and urokinase-type plasminogen activators. Fibrinolysis and Proteolysis. 2. 123–123. 3 indexed citations

12.

Kluft, Cornelis, H K Nieuwenhuis, D C Rijken, et al.. (1987). alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.. Journal of Clinical Investigation. 80(5). 1391–1400. 39 indexed citations

13.

Wijngaards, G., et al.. (1986). Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thrombosis Research. 42(6). 749–760. 23 indexed citations

14.

Rijken, D.C. & E. Groeneveld. (1986). Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator.. Journal of Biological Chemistry. 261(7). 3098–3102. 57 indexed citations

15.

Kluft, Cornelis, G. Wijngaards, A F H Jie, & E. Groeneveld. (1985). Appropriate Milieu for the Assay of Alpha-2-Antiplasmin Activity with Chromogenic Substrates. Pathophysiology of Haemostasis and Thrombosis. 15(3). 198–203. 7 indexed citations

16.

Wijngaards, G., C. Kluft, & E. Groeneveld. (1982). DEMONSTRATION OF UROKINASE‐RELATED FIBRINOLYTIC ACTIVITY IN HUMAN PLASMA. British Journal of Haematology. 51(1). 165–169. 62 indexed citations

17.

Nieuwenhuizen, W., G. Wijngaards, & E. Groeneveld. (1978). Fluorogenic Substrates for Sensitive and Differential Estimation of Urokinase and Tissue Plasminogen Activator. Pathophysiology of Haemostasis and Thrombosis. 7(2-3). 146–149. 9 indexed citations

18.

Nieuwenhuizen, W., G. Wijngaards, & E. Groeneveld. (1977). Synthetic substrates and the discrimination between urokinase and tissue plasminogen activator activity. Thrombosis Research. 11(1). 87–89. 17 indexed citations

19.

Nieuwenhuizen, W., G. Wijngaards, & E. Groeneveld. (1977). Fluorogenic peptide amide substrates for the estimation of plasminogen activators and plasmin. Analytical Biochemistry. 83(1). 143–148. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact